- Home
- CMPS vs AGS Comparison
CMPS vs AGS Comparison
Compare CMPS & AGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPS
- AGS
- Stock Information
- Founded
- CMPS 2020
- AGS 2005
- Country
- CMPS United Kingdom
- AGS United States
- Employees
- CMPS N/A
- AGS N/A
- Industry
- CMPS Biotechnology: Pharmaceutical Preparations
- AGS Miscellaneous manufacturing industries
- Sector
- CMPS Health Care
- AGS Consumer Discretionary
- Exchange
- CMPS Nasdaq
- AGS Nasdaq
- Market Cap
- CMPS 422.4M
- AGS 485.4M
- IPO Year
- CMPS 2020
- AGS 2018
- Fundamental
- Price
- CMPS $4.21
- AGS $12.09
- Analyst Decision
- CMPS Strong Buy
- AGS Hold
- Analyst Count
- CMPS 6
- AGS 4
- Target Price
- CMPS $29.60
- AGS $12.63
- AVG Volume (30 Days)
- CMPS 1.2M
- AGS 300.1K
- Earning Date
- CMPS 02-27-2025
- AGS 03-04-2025
- Dividend Yield
- CMPS N/A
- AGS N/A
- EPS Growth
- CMPS N/A
- AGS 150.52
- EPS
- CMPS N/A
- AGS 0.17
- Revenue
- CMPS N/A
- AGS $386,033,000.00
- Revenue This Year
- CMPS N/A
- AGS $10.87
- Revenue Next Year
- CMPS N/A
- AGS $4.46
- P/E Ratio
- CMPS N/A
- AGS $71.10
- Revenue Growth
- CMPS N/A
- AGS 12.18
- 52 Week Low
- CMPS $3.17
- AGS $8.23
- 52 Week High
- CMPS $12.75
- AGS $12.11
- Technical
- Relative Strength Index (RSI)
- CMPS 48.38
- AGS 68.57
- Support Level
- CMPS $3.99
- AGS $12.06
- Resistance Level
- CMPS $4.88
- AGS $12.10
- Average True Range (ATR)
- CMPS 0.41
- AGS 0.03
- MACD
- CMPS -0.01
- AGS -0.01
- Stochastic Oscillator
- CMPS 26.89
- AGS 85.92
About CMPS COMPASS Pathways Plc American Depository Shares
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find better ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.
About AGS PlayAGS Inc.
PlayAGS Inc is a designer and supplier of gaming products and services for the gaming industry. The company mainly supplies electronic gaming machines (EGM), server-based systems and back-office systems which are used by casinos, and various gaming locations. Its operating segments are EGM, Table Products, and Interactive. The EGM segment offers a selection of video slot titles developed for the world-wide marketplace as well as EGM cabinets. Its Table Products segments include live proprietary table games and side bets, as well as ancillary table products. The Interactive segment consists of delivering games through mobile apps such as Lucky Play Casino and Vegas Fever. It earns a majority of its revenue from Electronic Gaming Machines segment and geographically from the United States.